Acta Pharmacologica Sinica·18 AugOxyberberine-nanoparticle attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating gut microbiota through suppressing CXCL10/CXCR3 pathwayExperiments in animalsInterventionsPaper